Ipamorelin
Refilling Soon
This peptide is currently out of stock. Get notified the moment it's available.
About Ipamorelin
Ipamorelin is a selective, third-generation GHRP pentapeptide distinguished by its highly specific action at the ghrelin/GHSR-1a receptor with minimal off-target hormone activation. Unlike GHRP-2 and GHRP-6, Ipamorelin produces robust, dose-dependent GH pulses without significant concurrent elevation of cortisol, prolactin, or ACTH — a selectivity profile that makes it one of the most important research tools for studying isolated GH axis biology. This clean pharmacological signature means researchers can attribute experimental outcomes specifically to GH axis modulation rather than confounding hormonal effects. Ipamorelin is most frequently studied in combination with CJC-1295 (no DAC), where the GHRP/GHRH synergy produces amplified GH pulses that closely mimic the body's natural pulsatile secretion pattern. Published research has investigated Ipamorelin in bone density models, lean body composition studies, GH-deficiency replacement research, and anti-aging biology protocols. Its predictable kinetics, minimal side-effect profile, and high selectivity make it the preferred starting compound for GH secretagogue research programmes globally. Synthesised to ≥99% HPLC purity with ESI-MS verification.
Usage Guidelines
✓ Suitable For
- Gold-standard selective GHRP for clean GH axis research without hormonal confounders
- Ideal stacked with CJC-1295 no DAC for synergistic GH pulse amplification studies
- Suitable for bone density body composition and anti-aging research models
- Preferred first GHRP compound for new GH secretagogue research programmes
✗ Not Recommended For
- Not for use without a qualified research or medical professional overseeing the protocol
- Avoid in individuals with known pituitary pathology in research settings
- Not intended for human therapeutic use outside of approved clinical research
- Do not freeze reconstituted solution — store refrigerated and use within 28 days